Reminder - Neurocrine Biosciences Sets New Date for First Quarter 2004
Earnings Conference Call and Webcast
Earnings Conference Call and Webcast
Conference Call and Webcast Rescheduled for Monday, May 3, 2004
SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company is rescheduling its first quarter 2004 earnings announcement and conference call in light of the timing and potential conflicts with the Deutsche Bank Healthcare Conference. Neurocrine will now release its first quarter 2004 financial results on Monday morning, May 3, 2004 at 7:00 AM Eastern Time (ET) / 4:00 AM Pacific Time (PT). That same morning, Monday, May 3, 2004 at 11:00 AM (ET) / 8:00 AM (PT), the Company will host a live conference call and Webcast. Members from Neurocrine's senior management team will discuss the financial results and provide an update on the Company's research and development progress.
Participants may access the live Conference Call by dialing 1-800-905-0392 (U.S.) or 785-832-0326 (International). The call can also be accessed via the Webcast through the Company's website at http://www.neurocrine.com or alternatively through a link provided by PRNewswire at http://www.firstcallevents.com/service/ajwz405325797gf12.html.
If you are unable to attend the Webcast and would like further information on this announcement please contact Claudia Jones or Elizabeth Foster in the Investor Relations Department at Neurocrine Biosciences at (858) 658-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 1-888-567-0677 (US) or 402- 530-0419 (International) and will be archived until Monday, May 17, 2004.
Neurocrine Biosciences, Inc. is a product-based biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world including insomnia, anxiety, depression, malignant brain tumors and peripheral cancers, diabetes, multiple sclerosis, irritable bowel syndrome, eating disorders, pain, stroke, and certain female health disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the Internet at http://www.neurocrine.com.
SOURCE Neurocrine Biosciences, Inc.